Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-01-23
1990-02-20
Schofer, Joseph L.
Drug, bio-affecting and body treating compositions
Lymphokine
424 78, 424 851, 514 2, 530351, A61K 31745, A61K 3174, A61K 3900, A61K 3700
Patent
active
049025023
ABSTRACT:
The present invention is a process for preparing a pharmaceutical composition comprising a biologically active conjugated protein. It comprises a polyethylene glycol or a polyoxyethylated polyol conjugated to IL-2. This protein is conjugated to reduce its immunogenicity, and increase it solubility, and increase its circulating in vivo half-life.
REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 4412989 (1983-11-01), Iwashita et al.
patent: 4732863 (1988-03-01), Tomasi et al.
patent: 4766106 (1988-08-01), Katre et al.
patent: 4794002 (1988-12-01), Hems et al.
Beauchamp et al., 1983, Anal. Biochem. 131:25-33.
Veronese et al., 1985, Applied Biochemistry and Biotechnology 11:141-152.
Aldwin Lois
Goodson Robert J.
Katre Nandini
Nitecki Danute E.
Cetus Corporation
Halluin Albert P.
McGarrigle Philip L.
Pili-Curtis Carmen B.
Schofer Joseph L.
LandOfFree
Preparation of a polymer/interleukin-2 conjugate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of a polymer/interleukin-2 conjugate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of a polymer/interleukin-2 conjugate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1615247